Forwarded from: MUM Development Office <developm...@mum.edu>
<mailto:developm...@mum.edu?subject=subscribe&body=Please%20enter%20the%20following%20information%20to%20complete%20your%20subscription%20to%20Achievements!%20%0A%0D%20Name:%20%0A%0D%20Address:%20%0A%0D%20City:%20%0A%0D%20State%20and%20Zip:>
<https://giving.mum.edu/achievements/achievements-archive/>
January 27, 2019 • ISSUE 463
University Website <http://www.mum.edu/>
PTSD affects 10 to 20 percent of veterans
<http://www.mum.edu/assets/achievements/2019_01_27_photo.html>The graph shows
improvement in overall PTSD symptoms and depression for each treatment group.
The findings indicated significant reductions in PTSD symptoms and depression
for the TM group compared to health exposure; and ‘non-inferiority’ between TM
and prolonged exposure, indicating that TM was comparable to prolonged exposure
in reducing PTSD symptoms and depression.. (see larger view
<http://www.mum.edu/assets/achievements/2019_01_27_photo..html>)
<http://www.mum.edu/assets/achievements/2019_01_27_photo.html>Findings
indicated that 61 percent of the veterans assigned to learn and practice the TM
technique experienced clinically meaningful improvement in PTSD symptoms,
compared to 42 percent with prolonged exposure therapy, and 32 percent with
health education. Clinically meaningful improvement is defined as a reduction
of 10 or more points on the CAPS PTSD scale. (see larger view
<http://www.mum.edu/assets/achievements/2019_01_27_photo.html>)
Sanford Nidich, EdD, director of the Center for Social-Emotional Health and
Consciousness at Maharishi University of Management Research Institute
New Study on TM and PTSD Published in The Lancet Psychiatry
Veterans with post-traumatic stress disorder (PTSD) who practiced the
Transcendental Meditation® technique showed significant reductions in PTSD
symptoms comparable to veterans who utilized a gold standard prolonged exposure
therapy, according to a new study published in The Lancet Psychiatry journal
<https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(18)30384-5/fulltext>.
Both Transcendental Meditation and exposure therapy treatments were
significantly more effective than the PTSD health education control group.
Major news outlets around the world covered the findings. The Associated Press
(AP) story was picked up by The New York Times, The Washington Post, NBC News,
and ABC News.
The randomized controlled trial assigned a total of 203 veterans at the VA San
Diego Healthcare System to prolonged exposure, Transcendental Meditation, or
health education control groups. Each treatment provided 12 sessions over 12
weeks, with daily home practice. The objective of the study was to compare TM
to prolonged exposure in a non-inferiority clinical trial, and to compare both
to an attention control of health education.
Findings indicated that 61 percent of the veterans assigned to Transcendental
Meditation experienced clinically meaningful improvement in PTSD symptoms,
compared to 42 percent with prolonged exposure and 32 percent with health
education. Results further indicated significant reductions in depression and
mood disturbance and improved quality of life for TM® compared to health
education controls.
“PTSD is a complex and difficult-to-treat disorder that affects 10 to 20
percent of veterans,” said Sanford Nidich, EdD, director of the Center for
Social-Emotional Health and Consciousness at Maharishi University of Management
Research Institute and the study’s principal investigator. “This trial provides
evidence that Transcendental Meditation, a non-trauma-focused therapy, is a
viable option for decreasing PTSD symptoms in veterans. The availability of an
additional evidence-based PTSD therapy will benefit patients both by offering
them a greater range of first-line treatment options and by serving as an
alternative treatment strategy for those not responding to exposure-based PTSD
therapy.”
The Department of Defense, US Army Medical Research, sponsored the study for
$2.4 million. The VA San Diego Healthcare System, The University of California
San Diego School of Medicine, Georgetown University Medical School, and
Maharishi University of Management Research Institute collaborated on the
trial. Other MUM coauthors included Maxwell Rainforth, Robert Schneider, John
Salerno, and Carolyn Gaylord-King.
Development Office <http://www.mum.edu/giving>, Maharishi University of
Management
1000 North 4th Street, Fairfield, IA 52557 • 641-472-1180
Shop online at AmazonSmile <https://smile.amazon.com/ch/42-1315493> and the
University will benefit from your purchases.
Contribute to the Annual Fund <https://giving.mum.edu/giving-areas/annual-fund/>
Visit our website on Legacy Giving <http://mum.giftlegacy.com/>
Copyright 2019, Maharishi University of Management. Publication or reproduction
of this communication in any form is prohibited without permission.
Transcendental Meditation®, TM®, and Maharishi University of Management® are
protected trademarks and are used in the U.S. under license or with permission.
